Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Radiobiologiia ; 25(5): 656-60, 1985.
Artigo em Russo | MEDLINE | ID: mdl-2933761

RESUMO

The cytogenetic analysis was performed in the bone marrow cells of Wistar rats treated with a therapeutic dose of thaliblastine (250 mg/kg) and exposed to gamma-rays (2 Gy). Thaliblastine alone induced chromosome aberrations and polyploid cells. The latter were the result of the stathmokinetic effect of the drug. In contrast to gamma-radiation of 2 Gy thaliblastine elicited a minor mutagenic effect. The cytogenetic effect of the combined treatment is greater than the sum of the two agents delivered separately, the maximum effect of radiation and thaliblastine being exhibited on the 8th and the 12th hour, respectively. The difference between the sum of aberrations after separate treatments and the yield of aberrations after the combined treatment is due to chromatid fragments.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Aporfinas/farmacologia , Medula Óssea/efeitos dos fármacos , Radiogenética , Animais , Medula Óssea/efeitos da radiação , Radioisótopos de Césio , Aberrações Cromossômicas , Raios gama , Masculino , Índice Mitótico/efeitos dos fármacos , Índice Mitótico/efeitos da radiação , Ratos , Ratos Endogâmicos
2.
Radiobiologiia ; 23(4): 562-5, 1983.
Artigo em Russo | MEDLINE | ID: mdl-6611890

RESUMO

Samples of human whole blood were exposed in CMF (field induction, 0.3 T) for 15, 30, 45, 60, 75, 90, 120, 150, 180, 240, 300 or 360 min. 15 min following exposure, the samples were gamma-irradiated in a dose of 0.0516 C/kg (137Cs) at a dose rate of 1.95 A/kg. The following chromosome aberrations were scored: deletions dicentrics, rings, and symmetrical exchanges. Exposure of the blood in CMF for 15 to 360 min decreased radiation damage to cells as compared with unexposed irradiated samples. The extention of time from 15 to 180 min increases the effect the smallest amount of chromosome damages being scored at 150-180 min. A 2.8 - fold, 3 - fold and 3.5 - fold decrease was registered in the number of aberrant cells, deletions and dicentrics, respectively. With increasing time of exposure (240 min), the radiomodifying effect started decreasing, and with 300-360 min exposure it was the same as that observed at 15-45 min.


Assuntos
Aberrações Cromossômicas , Linfócitos/efeitos da radiação , Magnetismo , Radioisótopos de Césio , Raios gama , Humanos , Fatores de Tempo
3.
Genetika ; 18(7): 1164-8, 1982 Jul.
Artigo em Russo | MEDLINE | ID: mdl-6889553

RESUMO

Peripheral blood of 4 healthy donors was exposed to deutrons with the energy 4,2 GeV/nuclone and the intensivity of 4 to 6.10(10) particles per impulse, the capacity of the dose being 0,008 Gr/sec. The LPE of deutrons was 2,14 MeV sm2/g. Irradiation doses were 0,26; 0,49; 0,97; 2,02; 3,80 Gr. 15-20 min prior to irradiation, the protector adeturone was added at a concentration of 550 micrograms/ml of blood. Chromosome aberrations were analyzed in protected and unprotected blood samples. The results were treated using the method of variance and regression analysis. The correlative correspondence between the number of chromosome aberrations and an approximate dose of actual irradiation was established as Y = 0,13 d + 6,55.10(-4) D2 for dicentrics and as 0,26 D + 12,6.10(-4) D2 + 4,5 for the total percentage of aberrations. The pattern of the dose - effect dependence was retained in protected samples. The calculated values of the factor of dose decrease confirmed antiirradiation properties of adeturone.


Assuntos
Trifosfato de Adenosina/análogos & derivados , Aberrações Cromossômicas , Deutério , Linfócitos/efeitos da radiação , Protetores contra Radiação/farmacologia , beta-Aminoetil Isotioureia/análogos & derivados , Trifosfato de Adenosina/farmacologia , Relação Dose-Resposta à Radiação , Humanos , Técnicas In Vitro , Linfócitos/efeitos dos fármacos , Tolerância a Radiação , beta-Aminoetil Isotioureia/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA